up to now couple of years, the UK has witnessed a revolution in healthcare bodyweight‑loss remedies — with the introduction of semaglutide (Wegovy®) to the increasing acceptance of tirzepatide (Mounjaro®). Now, Yet another title is drawing notice in both equally clinical and general public wellne